The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer
Discover Oncology · 30.09.2024 · 15 (1)
DOI: 10.1007/s12672-024-01184-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 30.09.2024. Verfasst von Ying Peng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, the First Affiliated Hospital, Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Repub…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Training Program for Medical High-level Academic Leaders, Bose Talent Highland, Building Projects of Guangxi Bagui Scholars.
Abstract (Originalsprache)
Background
Long non-coding RNAs (lncRNAs) are a distinct class of RNAs with longer than 200 base pairs that are not translated into proteins. Small Nucleolar RNA Host Gene 3 (SNHG3) is a lncRNA and frequently dysregulated in various human cancers.
Objective
This review provides a comprehensive analysis of current research on lncRNA SNHG3, focusing on its role within the competitive endogenous RNA (ceRNA) network and its implications in cancer.
Methods
A systematic literature review was conducted using PubMed up to October 2023. The search strategy included keywords such as “lncRNA SNHG3”, “competitive endogenous RNA”, “cancer”, and related terms. Studies were selected based on relevance to SNHG3's involvement in cancer pathogenesis and progression.
Results
Disruptions in the ceRNA network involving lncRNA SNHG3 can impair normal cell growth and differentiation, significantly contributing to disease pathogenesis, particularly cancer. This review highlights SNHG3's substantial impact on various cancer processes and its potential as a diagnostic and therapeutic tool for aggressive cancers.
Conclusion
The findings underscore SNHG3's pivotal role in cancer prevention, diagnosis, and treatment, laying a foundation for future research in cancer management. Insights from this review emphasize the necessity for further exploration and development of SNHG3-based diagnostic and therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, the First Affiliated Hospital, Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
- Department of Pathology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, 518000, Guangdong, People's Republic of China.
- Department of Pathology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi Zhuang Autonomous Region, Baise, 533000, People's Republic of China.
- Department of Pathology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi Zhuang Autonomous Region, Baise, 533000, People's Republic of China. sjtulongxd@ymun.edu.cn.
- Department of Tumor Pathology, Key Laboratory of Tumor Molecular Pathology of Guangxi Higher Education Institutes, Guangxi Zhuang Autonomous Region, Baise, 533000, China. sjtulongxd@ymun.edu.cn.
ORCID-Profile: Xi-Dai Long
Förderung
- Guangxi Training Program for Medical High-level Academic Leaders
- Bose Talent Highland
- Building Projects of Guangxi Bagui Scholars
- Building Projects from the Key Laboratory of Molecular Pathology (Hepatobiliary Diseases) of Guangxi
- the Key Laboratory of Tumor Molecular Pathology of Guangxi Colleges & Universities
- Clinical Key Specialty Building Project (For Pathology) of Guangxi
Zitieren
APA
Peng, Y., & Long, X. D. (2024). The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01184-w
Vancouver
Peng Y, Long XD. The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01184-w
BibTeX
@article{Peng2024,
author = {Peng, Ying and Long, Xi-Dai},
title = {The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-01184-w}
}
EUVIMED